FilingReader Intelligence
Humanwell Healthcare gets clinical trial approval for lung drug
August 5, 2025 at 05:09 PM UTC•By FilingReader AI
Humanwell Healthcare Group has received approval for clinical trials of HW241045 tablets, a treatment for idiopathic pulmonary fibrosis.
The company has invested approximately 2.3bn yuan in the project. The drug will now proceed to clinical studies before seeking production approval.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600079•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Humanwell Healthcare Group publishes news
Free account required • Unsubscribe anytime